ATE392473T1 - Leptin-rezeptor db, für diesen kodierende nukleinsäuren und anwendungen desselben - Google Patents

Leptin-rezeptor db, für diesen kodierende nukleinsäuren und anwendungen desselben

Info

Publication number
ATE392473T1
ATE392473T1 AT97905602T AT97905602T ATE392473T1 AT E392473 T1 ATE392473 T1 AT E392473T1 AT 97905602 T AT97905602 T AT 97905602T AT 97905602 T AT97905602 T AT 97905602T AT E392473 T1 ATE392473 T1 AT E392473T1
Authority
AT
Austria
Prior art keywords
receptor
leptin
nucleic acids
applications
leptin receptor
Prior art date
Application number
AT97905602T
Other languages
English (en)
Inventor
Jeffrey FRIEDMAN
Gwo-Hwa Lee
Ricardo Proenca
Ella Ioffe
Original Assignee
Univ Rockefeller
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/586,594 external-priority patent/US7084252B1/en
Application filed by Univ Rockefeller filed Critical Univ Rockefeller
Application granted granted Critical
Publication of ATE392473T1 publication Critical patent/ATE392473T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/72—Receptors; Cell surface antigens; Cell surface determinants for hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2799/00—Uses of viruses
    • C12N2799/02—Uses of viruses as vector
    • C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid
    • C12N2799/026—Uses of viruses as vector for the expression of a heterologous nucleic acid where the vector is derived from a baculovirus

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Endocrinology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Molecular Biology (AREA)
  • Cell Biology (AREA)
  • Immunology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Cardiology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Emergency Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
AT97905602T 1996-01-16 1997-01-16 Leptin-rezeptor db, für diesen kodierende nukleinsäuren und anwendungen desselben ATE392473T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/586,594 US7084252B1 (en) 1996-01-16 1996-01-16 DB, the receptor for leptin
US08/599,974 US7063958B1 (en) 1996-01-16 1996-02-14 Nucleic acids db, the receptor for leptin

Publications (1)

Publication Number Publication Date
ATE392473T1 true ATE392473T1 (de) 2008-05-15

Family

ID=27079758

Family Applications (1)

Application Number Title Priority Date Filing Date
AT97905602T ATE392473T1 (de) 1996-01-16 1997-01-16 Leptin-rezeptor db, für diesen kodierende nukleinsäuren und anwendungen desselben

Country Status (12)

Country Link
US (1) US7063958B1 (de)
EP (1) EP0879286B1 (de)
JP (1) JP4285771B2 (de)
AT (1) ATE392473T1 (de)
AU (1) AU2244797A (de)
CA (1) CA2243446A1 (de)
DE (1) DE69738637T2 (de)
ES (1) ES2306456T3 (de)
IL (3) IL125353A (de)
MX (1) MX9805814A (de)
NZ (1) NZ511840A (de)
WO (1) WO1997026335A1 (de)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6310034B1 (en) 1993-05-21 2001-10-30 Ut-Battelle, Llc Agouti polypeptide compositions
US6001968A (en) 1994-08-17 1999-12-14 The Rockefeller University OB polypeptides, modified forms and compositions
US6287782B1 (en) * 1995-11-27 2001-09-11 Millennium Pharmaceuticals, Inc. Methods of using the Ob receptor to identify therapeutic compounds
US6620413B1 (en) 1995-12-27 2003-09-16 Genentech, Inc. OB protein-polymer chimeras
ES2244990T3 (es) * 1996-01-04 2005-12-16 Amgen Inc. Receptor de la proteina ob y composiciones y metodos relacionados.
US20050019325A1 (en) 1996-01-08 2005-01-27 Carter Paul J. WSX receptor agonist antibodies
US7074397B1 (en) 1996-01-08 2006-07-11 Genentech, Inc. Method for enhancing proliferation or differentiation of a cell using ob protein
US6541604B1 (en) 1996-01-08 2003-04-01 Genentech, Inc. Leptin receptor having a WSX motif
US6281346B1 (en) * 1996-03-22 2001-08-28 Merck & Co., Inc. Rat ob-receptors and nucleotides encoding them
WO1997046587A2 (en) * 1996-06-07 1997-12-11 Eli Lilly And Company Ob PROTEIN BINDING PROTEIN
WO1998006752A1 (en) * 1996-08-16 1998-02-19 The Rockefeller University A leptin binding protein and its use in methods for diagnosing and treating abnormalities of the endogenous leptin pathway
HUP9904023A3 (en) 1996-09-20 2002-01-28 Hoechst Ag Use of leptin antagonists for treating insulin resistance in type ii diabetes
EP0948595A4 (de) 1996-12-02 2002-11-06 Merck & Co Inc Mutierte ob-rezeptoren und nukleotide, welche fuer diese kodieren
WO1998057177A1 (en) * 1997-06-09 1998-12-17 Regeneron Pharmaceuticals, Inc. Assay systems for leptin-enhancing agents
US6770444B2 (en) 1998-07-16 2004-08-03 Synaptic Pharmaceutical Corporation Methods of identifying or screening for agents that binds the Ob-Re
CA2335107C (en) 1998-07-28 2010-01-19 Vlaams Interuniversitair Instituut Voor Biotechnologie Vzw Leptin-mediated gene-induction
US6777388B1 (en) 1998-08-21 2004-08-17 Clf Medical Technology Acceleration Program, Inc. Leptin-related peptides
EP1191945A4 (de) * 1999-06-11 2003-04-23 Baylor College Medicine Verfahren und zusammensetzungen zur kontrolle der knochenbildung mittels modulation der leptin-aktivität
AU767068B2 (en) * 1999-06-11 2003-10-30 Baylor College Of Medicine Methods and compositions for control of bone formation via modulation of leptin activity
JP4756813B2 (ja) 2000-05-22 2011-08-24 フラームス・インテルウニフェルシタイル・インステイチュート・フォール・ビオテヒノロヒー・ヴェーゼットウェー（ヴェーイーベー・ヴェーゼットウェー） レセプターを用いた相互作用の捕捉法
US7235629B2 (en) * 2000-11-14 2007-06-26 Vlaams Interuniversitair Instituut Voor Biotechnologie Vzw Functional fragment of the leptin receptor
ES2294048T3 (es) * 2000-11-14 2008-04-01 Vlaams Interuniversitair Instituut Voor Biotechnologie Vzw. Fragmento funcional de receptor de leptina.
US6992174B2 (en) 2001-03-30 2006-01-31 Emd Lexigen Research Center Corp. Reducing the immunogenicity of fusion proteins
AU2002315165A1 (en) * 2001-06-14 2003-01-02 Genelink, Inc. Kits and methods for assessing leptin-mediated lipid matabolism
CA2585549A1 (en) 2004-11-18 2006-05-26 Vib Vzw Novel type leptin receptor antagonist
UA127678C2 (uk) 2016-11-08 2023-11-29 Редженерон Фармасьютікалс, Інк. Виділене антитіло, яке зв'язується з лептиновим рецептором людини
MX2020010547A (es) 2018-04-06 2020-11-06 Regeneron Pharma Anticuerpo agonista del receptor de leptina para usarse en el tratamiento de una disfuncion metabolica o hipoleptinemia.

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1990014092A1 (en) 1989-05-18 1990-11-29 Cell Genesys, Inc. Single-strand site-directed modification of mammalian genes in vivo
US5194596A (en) * 1989-07-27 1993-03-16 California Biotechnology Inc. Production of vascular endothelial cell growth factor
US5350836A (en) * 1989-10-12 1994-09-27 Ohio University Growth hormone antagonists
WO1991006666A1 (en) 1989-11-06 1991-05-16 Cell Genesys, Inc. Production of proteins using homologous recombination
AU645294B2 (en) 1989-12-22 1994-01-13 Merck Serono Sa Endogenous gene expression modification with regulatory element
KR100246529B1 (ko) 1990-12-14 2000-04-01 스티븐 에이. 서윈. 엠.디. 수용체 관련된 신호 변환 경로를 위한 키메라 사슬
AU5098193A (en) * 1992-09-01 1994-03-29 Berlex Laboratories, Inc. Glycolation of glycosylated macromolecules
IL107378A (en) * 1993-10-24 2005-05-17 Yeda Res & Dev SOLUBLE INTERFERON alpha-RECEPTOR, ITS PREPARATION AND USE
US5912123A (en) 1994-09-14 1999-06-15 Progenitor, Inc. Detection of the leptin receptor in reproductive organs and methods for regulating reproductive biology
US5643748A (en) * 1994-09-14 1997-07-01 Progenitor, Inc. HU-B1.219, a novel human hematopoietin receptor
CA2218529A1 (en) * 1995-05-08 1996-11-14 Chiron Corporation Nucleic acids for treating obesity
AUPN564195A0 (en) 1995-09-26 1995-10-19 Walter And Eliza Hall Institute Of Medical Research, The A novel haemopoietin receptor and genetic sequences encoding same
US6506877B1 (en) * 1995-11-27 2003-01-14 Millennium Pharmaceuticals, Inc. Ob receptor
US6482927B1 (en) * 1995-11-27 2002-11-19 Millennium Pharmaceuticals, Inc. Chimeric proteins comprising the extracellular domain of murine Ob receptor
ES2244990T3 (es) 1996-01-04 2005-12-16 Amgen Inc. Receptor de la proteina ob y composiciones y metodos relacionados.
US20020193571A1 (en) * 1996-01-08 2002-12-19 Paul J. Carter Wsx receptor agonist antibodies
AU1833197A (en) 1996-01-18 1997-08-11 Progenitor, Inc. Detection of a leptin receptor variant and methods for regulating obesity
EP0922052A4 (de) 1996-02-22 2001-08-01 Merck & Co Inc Ratten-spezifische ob-rezeptoren und nukleotide, welche für diese kodieren
WO1997040380A1 (en) 1996-04-22 1997-10-30 Merck & Co., Inc. Leptin assay
AU2408397A (en) 1996-04-30 1997-11-19 Otsuka Pharmaceutical Co., Ltd. Ob protein receptor genes and use of the same
JP2000512486A (ja) 1996-05-06 2000-09-26 メルク エンド カンパニー インコーポレーテッド Ｏｂレセプターイソ型及びそれらをコードする核酸

Also Published As

Publication number Publication date
IL125353A (en) 2009-07-20
EP0879286A1 (de) 1998-11-25
IL195948A (en) 2010-12-30
JP4285771B2 (ja) 2009-06-24
CA2243446A1 (en) 1997-07-24
EP0879286B1 (de) 2008-04-16
ES2306456T3 (es) 2008-11-01
IL208750A0 (en) 2010-12-30
MX9805814A (es) 1998-12-31
AU2244797A (en) 1997-08-11
US7063958B1 (en) 2006-06-20
IL125353A0 (en) 1999-03-12
DE69738637T2 (de) 2009-05-28
NZ511840A (en) 2005-02-25
DE69738637D1 (de) 2008-05-29
JP2000504938A (ja) 2000-04-25
WO1997026335A1 (en) 1997-07-24

Similar Documents

Publication Publication Date Title
ATE392473T1 (de) Leptin-rezeptor db, für diesen kodierende nukleinsäuren und anwendungen desselben
Podolin et al. Differential glycosylation of interleukin 2, the molecular basis for the NOD Idd3 type 1 diabetes gene?
UA93653C2 (ru) Выделенное антитело, kotopoe специфически связывается c человеческим рецептором il-4 (il-4r)
WO1999006545A8 (en) Composition and method for the detection of diseases associated with amyloid-like fibril or protein aggregate formation
WO2001055327A8 (en) Nucleic acids, proteins, and antibodies
ATE182901T1 (de) Für androgen-rezeptor-protein kodierende dna
DK1005540T3 (da) IKK-beta-proteiner, nukleinsyrer og fremgangsmåder
BR9914066A (pt) Polipeptìdio degradador de c3 de complemento humano de streptococcus pneumoniae
MXPA03003902A (es) Polipeptidos de proquineticina, composiciones relacionadas y metodos.
ATE490323T1 (de) Adiponektin-rezeptor und dafür kodierendes gen
PT907731E (pt) Receptores gaba[b] metabotropicos, ligandos especificos dos receptores e suas utilizacoes
PE20010516A1 (es) Peptidos ciclicos con afinidad mejorada por los receptores de somatostatina
EP1005539A4 (de) Ikk-alpha proteine, nukleinsäuren und verfahren
Rivera et al. Differential effect of chronic morphine on mRNA encoding adenylyl cyclase isoforms: relevance to physiological sequela of tolerance/dependence
AP2000001917A0 (en) Gene encoding labyrinthin, a marker for cancer.
ATE287952T1 (de) Humanes thymosin beta 15 gen,protein und dessen verwendungen
Dufresne et al. Molecular cloning, developmental expression and pharmacological characterization of the CCKBgastrin receptor in the calf pancreas
Brar et al. An Ets motif in the proximal decidual prolactin promoter is essential for basal gene expression
Qiu et al. Carboxyl-methylation of Rab3D in the rat pancreatic acinar tumor cell line AR42J
Yang et al. Identification of a 70-kDa gastrin-binding protein on DLD-1 human colorectal carcinoma cells
Horuk et al. Partial purification and characterization of the glucagon receptor
NO973876D0 (no) Human-DNase I-varianter
Matsumoto et al. Hypophosphorylation of Topoisomerase IIα in Etoposide (VP‐16)‐resistant Human Carcinoma Cell Lines Associated with Carboxy‐terminal Truncation
AU1214202A (en) Coactivation of nuclear receptors
DK1100913T3 (da) MEKK 1 serin threonin kinaser - interagerende, FHA forkhead associeret domæneprotein 1 (MIF 1)

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties